Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 9 studies | 47% ± 23% | |
adipocyte | 9 studies | 54% ± 16% | |
GABAergic neuron | 5 studies | 38% ± 18% | |
oligodendrocyte precursor cell | 5 studies | 27% ± 13% | |
fibroblast | 4 studies | 21% ± 5% | |
granule cell | 3 studies | 48% ± 17% | |
glycinergic amacrine cell | 3 studies | 41% ± 9% | |
retinal ganglion cell | 3 studies | 46% ± 13% | |
brush cell | 3 studies | 27% ± 7% | |
interneuron | 3 studies | 40% ± 17% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
kidney | 100% | 550.04 | 89 / 89 | 79% | 5.89 | 715 / 901 |
pancreas | 100% | 1677.35 | 328 / 328 | 32% | 1.02 | 57 / 178 |
ovary | 100% | 884.59 | 180 / 180 | 13% | 0.57 | 55 / 430 |
uterus | 95% | 660.31 | 162 / 170 | 14% | 0.62 | 62 / 459 |
lung | 97% | 523.41 | 563 / 578 | 8% | 0.25 | 87 / 1155 |
prostate | 90% | 386.04 | 221 / 245 | 15% | 0.26 | 73 / 502 |
brain | 79% | 792.07 | 2095 / 2642 | 25% | 0.90 | 178 / 705 |
bladder | 71% | 436.43 | 15 / 21 | 31% | 1.03 | 157 / 504 |
intestine | 85% | 245.17 | 822 / 966 | 17% | 0.35 | 88 / 527 |
spleen | 100% | 727.70 | 240 / 241 | 0% | 0 | 0 / 0 |
adipose | 97% | 525.88 | 1173 / 1204 | 0% | 0 | 0 / 0 |
breast | 80% | 402.66 | 369 / 459 | 2% | 0.04 | 21 / 1118 |
adrenal gland | 17% | 38.16 | 43 / 258 | 48% | 2.91 | 111 / 230 |
blood vessel | 61% | 163.89 | 812 / 1335 | 0% | 0 | 0 / 0 |
stomach | 36% | 62.94 | 130 / 359 | 21% | 0.58 | 59 / 286 |
heart | 44% | 145.13 | 378 / 861 | 0% | 0 | 0 / 0 |
liver | 25% | 40.13 | 57 / 226 | 17% | 0.61 | 71 / 406 |
skin | 32% | 99.59 | 578 / 1809 | 7% | 1.02 | 33 / 472 |
esophagus | 19% | 31.88 | 268 / 1445 | 13% | 0.34 | 24 / 183 |
thymus | 12% | 19.15 | 76 / 653 | 3% | 0.11 | 21 / 605 |
muscle | 12% | 15.76 | 95 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 4% | 0.23 | 2 / 45 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007165 | Biological process | signal transduction |
GO_0006508 | Biological process | proteolysis |
GO_0043171 | Biological process | peptide catabolic process |
GO_0007267 | Biological process | cell-cell signaling |
GO_0005615 | Cellular component | extracellular space |
GO_0070062 | Cellular component | extracellular exosome |
GO_0016020 | Cellular component | membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0042277 | Molecular function | peptide binding |
GO_0016920 | Molecular function | pyroglutamyl-peptidase activity |
GO_0070006 | Molecular function | metalloaminopeptidase activity |
GO_0008270 | Molecular function | zinc ion binding |
GO_0004177 | Molecular function | aminopeptidase activity |
Gene name | TRHDE |
Protein name | Thyrotropin releasing hormone degrading enzyme Thyrotropin-releasing hormone-degrading ectoenzyme (TRH-DE) (TRH-degrading ectoenzyme) (EC 3.4.19.6) (Pyroglutamyl-peptidase II) (PAP-II) (TRH-specific aminopeptidase) (Thyroliberinase) |
Synonyms | UNQ2507/PRO5995 |
Description | FUNCTION: Specific inactivation of TRH after its release. |
Accessions | A0AA75K8V0 ENST00000547300.2 Q9UKU6 ENST00000261180.10 |